1. Home
  2. BTM vs PBYI Comparison

BTM vs PBYI Comparison

Compare BTM & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTM
  • PBYI
  • Stock Information
  • Founded
  • BTM 2016
  • PBYI 2010
  • Country
  • BTM United States
  • PBYI United States
  • Employees
  • BTM N/A
  • PBYI N/A
  • Industry
  • BTM Finance: Consumer Services
  • PBYI Biotechnology: Pharmaceutical Preparations
  • Sector
  • BTM Finance
  • PBYI Health Care
  • Exchange
  • BTM Nasdaq
  • PBYI Nasdaq
  • Market Cap
  • BTM 144.5M
  • PBYI 171.7M
  • IPO Year
  • BTM N/A
  • PBYI N/A
  • Fundamental
  • Price
  • BTM $4.64
  • PBYI $3.07
  • Analyst Decision
  • BTM Strong Buy
  • PBYI Strong Buy
  • Analyst Count
  • BTM 2
  • PBYI 1
  • Target Price
  • BTM $4.75
  • PBYI $7.00
  • AVG Volume (30 Days)
  • BTM 1.4M
  • PBYI 319.7K
  • Earning Date
  • BTM 08-12-2025
  • PBYI 08-07-2025
  • Dividend Yield
  • BTM N/A
  • PBYI N/A
  • EPS Growth
  • BTM N/A
  • PBYI 143.51
  • EPS
  • BTM N/A
  • PBYI 0.77
  • Revenue
  • BTM $599,390,000.00
  • PBYI $232,709,000.00
  • Revenue This Year
  • BTM $10.59
  • PBYI N/A
  • Revenue Next Year
  • BTM $4.27
  • PBYI N/A
  • P/E Ratio
  • BTM N/A
  • PBYI $3.97
  • Revenue Growth
  • BTM N/A
  • PBYI 2.68
  • 52 Week Low
  • BTM $0.93
  • PBYI $2.23
  • 52 Week High
  • BTM $6.88
  • PBYI $4.13
  • Technical
  • Relative Strength Index (RSI)
  • BTM 38.34
  • PBYI 33.07
  • Support Level
  • BTM $4.90
  • PBYI $3.23
  • Resistance Level
  • BTM $5.70
  • PBYI $3.41
  • Average True Range (ATR)
  • BTM 0.42
  • PBYI 0.13
  • MACD
  • BTM -0.14
  • PBYI -0.04
  • Stochastic Oscillator
  • BTM 3.15
  • PBYI 6.67

About BTM Bitcoin Depot Inc.

Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: